British medical bulletin
-
British medical bulletin · Oct 2020
Observational StudyOutcome of total hip and total knee arthroplasty and vitamin D homeostasis.
Low levels of vitamin D are common in patients undergoing total hip arthroplasty (THA) and total knee arthroplasty (TKA), but it is still unclear whether the outcome of such surgery is related to vitamin D levels. ⋯ Further studies should explore the possible causal relationship between vitamin D status and outcomes of THA and TKA and verify the laboratory methods to analyse it.
-
British medical bulletin · Oct 2020
Covid-19 and the 'new normal': are remote video consultations here to stay?
During the UK Covid-19 lockdown, video consultations (telemedicine) were encouraged. The extent of usage, and to which concerns to earlier implementation were set aside, is unknown; this is worthy of exploration as data becomes available. ⋯ Examination of telemedicine use during the Covid-19 crisis to ensure that the benefits and usage continue into the post-lockdown, 'new normal' world.
-
British medical bulletin · Oct 2020
The challenges presented by haematopoietic stem cell transplantation in children with primary immunodeficiency.
For many primary immunodeficiencies (PIDs), haematopoietic stem cell transplantation (HSCT) offers treatment to cure disease. However, patients with PID present a unique set of challenges when considering HSCT. ⋯ International collaborations are important to learn about rare presentations and complications, and to formulate the most effective and safe treatment strategies.
-
Tendon is a composite material with a well-ordered hierarchical structure exhibiting viscoelastic properties designed to transfer force. It is recognized that the incidence of tendon injury increases with age, suggesting a deterioration in homeostatic mechanisms or reparative processes. This review summarizes epigenetic mechanisms identified in ageing healthy tendon. ⋯ Metanalysis through integration of multiple datasets and platforms will enable a holistic understanding of the epigenome in ageing and its relevance to disease.
-
British medical bulletin · Oct 2020
Clozapine in the treatment of refractory schizophrenia: a practical guide for healthcare professionals.
Clozapine remains the only medication licensed for treating refractory schizophrenia. However, it remains underutilized in part due to concerns regarding adverse events. ⋯ There is a need for more research on assessing clozapine dosage (i) as patients get older, (ii) with respect to exposure to cigarette smoke and (iii) optimizing response if adverse events or other factors limit dosage.